Clinical Trial Update: Neujia Anastomosis for Treatment of Obesity and Type II Diabetes [NA]

View source ↗

Summary

A clinical trial (NCT03675074) assessing Neujia Anastomosis for obesity and Type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Neurotronic, Inc. | Conditions: Type2 Diabetes Mellitus, Obesity | NA | Status: WITHDRAWN